Biome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%

MT Newswires Live

Feb 05, 2025

Biome Australia (ASX:BIO) signed a co-investment agreement with Australia's Food and Beverage Accelerator for a jointly funded intellectual property development program for the company's BMB18 probiotic strain, according to a Wednesday filing with the Australian bourse.

Results of the company's initial in vitro studies on BMB18 showed the strain's functional potential in modulating immune responses, reducing inflammation, reducing oxidative stress, and maintaining intestinal barrier integrity, the filing said.

The agreement is backed by a AU$50 million grant awarded to the Food and Beverage Accelerator under the Australian Government Department of Education Trailblazer Program, per the filing.

Biome Australia shares rose nearly 5% in morning trade Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509414838"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509414838\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509414838?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 08:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509414838","market":"sh","top_or_hot":-1,"title":"Biome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%","media":"MT Newswires Live","content":"<html><body><p> Biome Australia (ASX:BIO) signed a co-investment agreement with Australia's Food and Beverage Accelerator for a jointly funded intellectual property development program for the company's BMB18 probiotic strain, according to a Wednesday filing with the Australian bourse.</p><p>Results of the company's initial in vitro studies on BMB18 showed the strain's functional potential in modulating immune responses, reducing inflammation, reducing oxidative stress, and maintaining intestinal barrier integrity, the filing said.</p><p>The agreement is backed by a AU$50 million grant awarded to the Food and Beverage Accelerator under the Australian Government Department of Education Trailblazer Program, per the filing.</p><p>Biome Australia shares rose nearly 5% in morning trade Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-05 08:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Biome Australia (ASX:BIO) signed a co-investment agreement with Australia's Food and Beverage Accelerator for a jointly funded intellectual property development program for the company's BMB18 probiotic strain, according to a Wednesday filing with the Australian bourse.</p><p>Results of the company's initial in vitro studies on BMB18 showed the strain's functional potential in modulating immune responses, reducing inflammation, reducing oxidative stress, and maintaining intestinal barrier integrity, the filing said.</p><p>The agreement is backed by a AU$50 million grant awarded to the Food and Beverage Accelerator under the Australian Government Department of Education Trailblazer Program, per the filing.</p><p>Biome Australia shares rose nearly 5% in morning trade Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7111","symbol_name":"个人用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509414838","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509414838","pubTimestamp":1738715246,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Biome Australia  signed a co-investment agreement with Australia's Food and Beverage Accelerator for a jointly funded intellectual property development program for the company's BMB18 probiotic strain, according to a Wednesday filing with the Australian bourse.Results of the company's initial in vitro studies on BMB18 showed the strain's functional potential in modulating immune responses, reducing inflammation, reducing oxidative stress, and maintaining intestinal barrier integrity, the filing said.The agreement is backed by a AU$50 million grant awarded to the Food and Beverage Accelerator under the Australian Government Department of Education Trailblazer Program, per the filing.Biome Australia shares rose nearly 5% in morning trade Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7111":"个人用品","XAO.AU":"标普/澳交所 普通股指数","BIO.AU":"BIOME AUSTRALIA LTD","BK4588":"碎股","BK4136":"纸材料包装","XJO.AU":"标普/澳交所 200指数","BK4585":"ETF&股票定投概念","IP":"国际纸业","LU2463526074.USD":"NORDEA 1 - GLOBAL CLIMATE ENGAGEMENT \"BP\" (USD) ACC","XKO.AU":"标普/澳交所 300指数"},"translate_title":"Biome Australia签署知识产权开发共同投资协议；股价上涨5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IP":1,"XAO.AU":1,"BIO.AU":0.9,"XJO.AU":1,"XKO.AU":1},"content_text":"Biome Australia (ASX:BIO) signed a co-investment agreement with Australia's Food and Beverage Accelerator for a jointly funded intellectual property development program for the company's BMB18 probiotic strain, according to a Wednesday filing with the Australian bourse.Results of the company's initial in vitro studies on BMB18 showed the strain's functional potential in modulating immune responses, reducing inflammation, reducing oxidative stress, and maintaining intestinal barrier integrity, the filing said.The agreement is backed by a AU$50 million grant awarded to the Food and Beverage Accelerator under the Australian Government Department of Education Trailblazer Program, per the filing.Biome Australia shares rose nearly 5% in morning trade Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}